Grace introduces ProVance Pre-packed Protein A Columns for mAb purification

W. R. Grace & Co. has introduced ProVance™ Pre-packed Protein A Columns, for purification of biologic drugs, specifically monoclonal antibodies (mAbs). Monoclonal antibodies represent the single largest biologics therapeutic category in the clinical development pipeline. ProVance™ Columns bring together Protein A resin and a convenient and cost effective pre-packed column format designed specifically for facilities sites that have moved to single-use manufacturing methodologies. 

The ProVance™ portfolio of disposable columns comes pre-packed with a new silica-based Protein A resin that has a higher capacity and lower cost than the leading alternative technology used for mAb purification. Biopharmaceutical customers have confirmed 40 to 60 percent total operational cost reduction with ProVance™ Columns by eliminating time-consuming cleaning and packing steps and achieving increased efficiency. The pre-packed disposable columns further improve biopharmaceutical productivity by lowering the risk of contamination and accelerating time to market.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.

or

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Fluidic Sciences acquires business and assets of Sphere Bio to accelerate single-cell and protein interaction discovery